AllianceBernstein Holding LP (AB) Stock News

Astera Labs (ALAB) has outperformed Cisco (CSCO) year-to-date with an 81.5% gain versus 42.6%, but Cisco is rated as offering greater upside potential due to stronger AI infrastructure momentum and robust networking demand. While ALAB benefits from strong adoption of its PCIe 6 products and expanding AI connectivity portfolio, rising operating expenses and competition are concerns. Cisco carries a Zacks Rank #2 (Buy) versus ALAB's Rank #3 (Hold).

Abits Group Inc (NASDAQ: ABTS) reported H1 2026 revenue of $3.20 million, down 20% year-over-year, primarily due to a 23% decline in Bitcoin output at the Duff site and significant BTC market downturn. The company posted a pre-tax loss of $2.54 million compared to $0.34 million loss in H1 2025. However, the newly operational Memphis site contributed 15.58 BTC and $1.2 million in revenue. The company secured $14 million in convertible note financing and appointed new leadership including CEO Stephen Faucetta.

A survey of 151 Transmission System Operators across North America, Europe, and Asia-Pacific reveals that cybersecurity is their top concern. TSOs are increasing software investments in Energy Management Systems, grid planning software, and Grid Enhancing Technologies to modernize aging infrastructure and expand grid capacity. Vendors are advised to emphasize security credibility, interoperability, and operational value rather than relying solely on AI differentiation.

AbbVie has recently attracted investor attention with shares returning +4.3% over the past month, outperforming the S&P 500's +2.1% gain. However, despite strong earnings growth expectations (+104.3% YoY for current quarter) and consistent beats on both EPS and revenue estimates, the company received a Zacks Rank #4 (Sell) rating due to recent downward revisions in consensus earnings estimates. The stock is valued at par with peers (C grade) but may underperform the broader market in the near term.

Westinghouse Air Brake Technologies (WAB) received an upgrade to Zacks Rank #2 (Buy) based on upward trends in earnings estimates. The company, which manufactures parts for locomotives, subways, and buses, is expected to earn $10.89 per share for fiscal year 2026. Analysts have steadily raised estimates over the past three months, with the Zacks Consensus Estimate increasing 2.3%, positioning the stock in the top 20% of Zacks-covered stocks for potential near-term gains.

Hexagon AB Unsponsored ADR is expected to report declining earnings and revenues for Q3 2026, with EPS projected at $0.09 (down 18.2% YoY) and revenues at $1.15 billion (down 24.6% YoY). The stock carries a Zacks Rank #4 and an Earnings ESP of 0%, making it difficult to predict an earnings beat. The company has beaten consensus estimates in 2 of the last 4 quarters.

Zacks analyzes three business services stocks amid industry challenges. Concentrix is transitioning to AI-enabled customer experience solutions with improving margins. Sodexo benefits from resilient outsourcing demand and strong Sodexo Live! performance. ABM is expanding in semiconductor, data center, and microgrid markets with strong organic growth. The broader Business Services industry faces headwinds with a Zacks Industry Rank of #173 and has underperformed the S&P 500 by 40.8% over the past 12 months.

Abbott (ABT) closed at $101.82, up 2.23%, outperforming the S&P 500's 0.06% decline. The company is expected to report Q3 earnings on October 21, 2026, with projected EPS of $1.42 (up 9.23% YoY) and revenue of $12.91 billion (up 13.52% YoY). Abbott holds a Zacks Rank #2 (Buy) rating and trades at a Forward P/E of 18.04, below its industry average of 19.61.

Grab Holdings (GRAB) declined 1.41% to $3.15, underperforming the S&P 500's 0.06% loss. Despite a monthly gain of 4.59%, the stock trails its sector. Analysts project strong earnings growth with EPS expected at $0.02 (100% increase YoY) and revenue of $1.07 billion (22.94% increase YoY). The company holds a Zacks Rank #3 (Hold) with a Forward P/E of 22.39, trading at a premium to its industry average.

Alibaba (BABA) is rated Zacks Rank #3 (Hold) with expected earnings growth of +144.3% for the current quarter and +67.1% for the fiscal year. The stock has returned +1.9% over the past month, underperforming the S&P 500's +2.4%. Revenue growth is projected at +14.8% for the current fiscal year. The company trades at par with peers with a C valuation grade, suggesting it may perform in line with the broader market in the near term.

The St. Louis Blues and Gray Media announced a multi-year partnership to simulcast 10 select Thursday night games over-the-air on ABC 32 in St. Louis and 10 other markets across the team's five-state broadcast territory during the 2026-27 season. The Thursday Night Blues package expands Gray's distribution of Blues games to over 4.8 million television households, doubling the number of over-the-air telecasts from the previous year.

PABU is a smart beta ETF with $2.5 billion in assets that tracks climate-aligned U.S. stocks. It has low expenses (0.10%), strong year-to-date performance (+11.29%), and heavy tech exposure (55.5%). The fund offers diversified exposure with 91 holdings, though it carries slightly higher volatility (beta 1.07) compared to traditional market-cap weighted alternatives.

Rosen Law Firm is reminding investors in Taboola.com Ltd., Hyliion Holdings Corp., and Tigo Energy, Inc. of upcoming lead plaintiff deadlines in securities class action lawsuits. The lawsuits allege that these companies made materially false and misleading statements regarding their business operations and financial prospects.

Astera Labs (ALAB) declined 1.39% to $342.21, underperforming the broader market which gained 0.6%. Despite the daily drop, the stock has gained 21.97% year-to-date, outpacing the tech sector. The company is expected to report earnings on November 3, 2026, with anticipated EPS of $1.19 (up 142.86% YoY) and revenue of $550.39 million (up 138.71% YoY). ALAB currently holds a Zacks Rank #3 (Hold) with a Forward P/E of 87.31, significantly above its industry average of 20.7.

Ambev (ABEV) is highlighted as a compelling growth stock opportunity, earning a Zacks Rank #2 (Buy) and Growth Score of B. The beverage company demonstrates strong fundamentals including projected EPS growth of 14.8% (vs. industry average of 2.8%), efficient asset utilization with an S/TA ratio of 0.63, and positive earnings estimate revisions trending upward by 1.6% over the past month.

Astera Labs announced Aries 7, the industry's first PCIe 7 signal-conditioning portfolio for copper and optical interconnects, with initial sampling expected in Q4 2026. The company's PCIe 6 products generated over 50% of Q2 revenues with record Aries sales. For Q3 2026, ALAB expects revenues between $540-560 million, representing ~40% sequential growth. The company faces competition from Marvell Technology and Credo Technology in the AI connectivity space.

Airbnb has been attracting investor attention with strong earnings growth expectations of 30.8% year-over-year for the current quarter and 31% for the fiscal year. The company maintains a Zacks Rank #2 (Buy) rating based on positive earnings estimate revisions. However, the stock has underperformed the S&P 500 over the past month (-5.3% vs +1.4%) and trades at a premium valuation with a D grade on the Value Style Score.

Airbnb (ABNB) has been highlighted as a solid growth stock choice, earning a Zacks Rank #2 (Buy) and Growth Score of B. The company is projected to deliver 31.1% EPS growth this year, significantly outpacing the industry average of 28.1%, with sales expected to grow 15.8% versus the industry average of 3.7%. Positive earnings estimate revisions and efficient asset utilization further support the recommendation for growth investors.

Pomerantz LLP is investigating potential securities fraud claims against Abeona Therapeutics following the company's August 13, 2026 disclosure that only four of five patient treatments with ZEVASKYN were recognized for revenue due to one batch lacking minimum sheet requirements. The announcement triggered a 14.95% stock price decline.

Genmab shares rallied 10.7% following positive phase III trial data for epcoritamab in combination with R-CHOP for newly diagnosed diffuse large B-cell lymphoma. The stock's consensus EPS estimate was revised 8.7% higher over the past 30 days, though earnings are expected to decline 43.1% year-over-year while revenues grow 15.7%. The stock carries a Zacks Rank #3 (Hold) rating.

Associated Builders and Contractors released its sixth annual construction technology report highlighting how contractors are using technology, data, and collaboration to improve health and safety outcomes. The report features case studies on wearable technologies, AI-powered risk detection, mental health initiatives, and connected jobsite solutions from leading construction companies and their technology partners.

Vallourec announces the appointment of Isabelle Quéméneur as Group Chief Digital and Information Officer, effective October 5, 2026. Quéméneur, previously Chief Technology Officer at Danone, joins Vallourec's Executive Committee to lead digital transformation initiatives focused on customer value creation and modernizing team operations in response to cybersecurity and AI challenges.

Vallourec announces the appointment of Isabelle Quéméneur as Director of Digital & IT Systems, effective October 5, 2026. She joins the Executive Committee and brings extensive experience from her previous role as CTO at Danone, along with a background in technology leadership at major international companies including Société Générale, AXA, and Sanofi.

Rosen Law Firm is reminding investors in Alibaba Group Holding Limited, Flotek Industries, Inc., and The Simply Good Foods Company of upcoming lead plaintiff deadlines in securities class actions. The Alibaba lawsuit alleges the company made false statements regarding military affiliations and AI model distillation attacks. Investors with losses exceeding $100,000 are encouraged to seek counsel before the October 5, 2026 deadline for Alibaba.

Rosen Law Firm is encouraging investors who purchased securities of Taboola.com Ltd. (NASDAQ: TBLA), Lincoln Educational Services Corporation (NASDAQ: LINC), and Flotek Industries, Inc. (NYSE: FTK) during specified class periods to join securities class action lawsuits. The firm alleges that defendants made materially false and misleading statements regarding business operations and financial prospects. The lead plaintiff deadline for the Taboola.com case is October 20, 2026.

Astera Labs (ALAB) declined 1.71% to $350.33, underperforming the broader market which gained 0.73%. Despite the daily drop, the stock has surged 26.02% over the prior period. The company maintains a Zacks Rank #1 (Strong Buy) rating with strong earnings growth expectations: EPS projected at $1.19 (up 142.86% YoY) and revenue at $550.39 million (up 138.71% YoY). However, the stock trades at a premium Forward P/E of 89.69 versus the industry average of 19.59.

AbbVie is a trending stock with strong earnings growth expectations of +40.5% for the current fiscal year and +14.8% for next year. The company has consistently beaten consensus estimates over the trailing four quarters. However, with a Zacks Rank #3 (Hold) rating and a C valuation grade indicating it trades at par with peers, the stock is expected to perform in line with the broader market in the near term.

Abbott stock closed down 2.1%, underperforming the S&P 500's 0.25% loss. The stock has declined 7.33% over the past month, significantly lagging the Medical sector. Upcoming earnings are expected to show $1.43 EPS (10% YoY growth) and $12.91B revenue (13.52% increase). Abbott holds a Zacks Rank #3 (Hold) with a Forward P/E of 18.28, trading at a discount to its industry average.

A class action lawsuit has been filed against Taboola.com Ltd. for allegedly making materially false and misleading statements regarding its business operations. The lawsuit claims the company failed to disclose an increase in low-quality publishers and overstated the value of publisher relationships, which would require aggressive exits impacting earnings. Investors who purchased securities between May 6, 2026 and August 4, 2026 can apply to be lead plaintiff by October 20, 2026.

AB KN Energies appointed Lasse Bolander as chair of its Remuneration and Appointment Committee on September 28, 2026. The committee comprises two independent board members and one state official board member. Additionally, KN Energies joined the Baltic Energy Initiative led by ORLEN, uniting 14 energy companies across nine Northern and Central European countries.